Question 1

Is Al(:betta approved by the FDA?

Accepted Answer

No. Al(:betta is an investigational auto-injector in development by Lent Innovations, LLC. It has not been approved or cleared by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other regulatory authority worldwide, and is not commercially available.

Question 2

Who is the Al(:betta investor portal intended for?

Accepted Answer

The portal is intended exclusively for institutional investors, strategic partners, and qualified financial professionals. It is not directed at patients, the general public, or retail investors.

Question 3

What makes Al(:betta different from existing epinephrine auto-injectors?

Accepted Answer

Al(:betta is engineered as an anxiety-free epinephrine auto-injector with zero needle visibility and 100% intramuscular bioavailability, designed for the panic moment of anaphylaxis. These are development-stage claims based on proprietary research and published literature.